Reported 278,400 shares, unchanged from the prior quarter.
Reported value 17.9%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-06-30 | 26657400 |
| 2023-09-30 | 51440519 |
| 2023-12-31 | 61302800 |
| 2024-03-31 | 67410200 |
| 2024-06-30 | 70441800 |
| 2024-09-30 | 88920000 |
| 2024-12-31 | 102701760 |
| 2025-03-31 | 121092864 |
| 2025-06-30 | 109258864 |
| 2025-09-30 | 110151608 |
| 2025-12-31 | 119502495 |
| 2026-03-31 | 66717725 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -227,900 (-100.0%) | 0 | $0 | 2026-08-14 | |
| Q1 2026 | Reduced | 227,900 | -113,000 (-33.1%) | 2.19% | $66,717,725 | 2026-05-15 | |
| Q4 2025 | Unchanged | 340,900 | 0 (0.0%) | 3.96% | $119,502,495 | 2026-02-17 | |
| Q3 2025 | Added | 340,900 | +60,000 (21.4%) | 3.44% | $110,151,608 | 2025-11-14 | |
| Q2 2025 | Added | 280,900 | +2,500 (0.9%) | 3.84% | $109,258,864 | 2025-08-14 | |
| Q1 2025 | Unchanged | 278,400 | 0 (0.0%) | 4.81% | $121,092,864 | 2025-05-15 | |
| Q4 2024 | Added | 278,400 | +107,400 (62.8%) | 3.89% | $102,701,760 | 2025-02-14 | |
| Q3 2024 | Added | 171,000 | +41,000 (31.5%) | 3.78% | $88,920,000 | 2024-11-14 | |
| Q2 2024 | Unchanged | 130,000 | 0 (0.0%) | 2.97% | $70,441,800 | 2024-08-14 | |
| Q1 2024 | Unchanged | 130,000 | 0 (0.0%) | 2.81% | $67,410,200 | 2024-05-15 | |
| Q4 2023 | Added | 130,000 | +11,860 (10.0%) | 2.92% | $61,302,800 | 2024-02-14 | |
| Q3 2023 | Added | 118,140 | +58,140 (96.9%) | 2.69% | $51,440,519 | 2023-11-14 | |
| Q2 2023 | New | 60,000 | +60,000 (0.0%) | 1.45% | $26,657,400 | 2023-08-30 |
Who else reported the position
1806 managers reported ELEVANCE HEALTH INC. for Q1 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Added | 22,152,108 | +666,534 | 0.17% | $9,635,280,896 | 42 qtrs |
| BlackRock Inc | Added | 21,311,015 | +868,829 | 0.19% | $9,269,439,181 | 3 qtrs |
| STATE STREET CORPORATION | Reduced | 10,647,703 | -34,590 | 0.19% | $4,631,324,897 | 38 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 9,142,563 | -1,475,499 | 0.49% | $3,976,650,000 | 42 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 5,794,794 | -560,738 | 0.48% | $2,520,503,599 | 42 qtrs |
| Capital International Investors | Added | 5,555,887 | +1,675,257 | 0.48% | $2,416,371,100 | 25 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 5,166,715 | +202,724 | 0.18% | $2,245,109,846 | 42 qtrs |
| Sanders Capital LLC | Reduced | 4,672,768 | -13,386 | 3.04% | $2,032,467,169 | 42 qtrs |
| Artisan Partners Limited Partnership | Added | 3,350,780 | +474,930 | 2.35% | $1,457,455,269 | 39 qtrs |
| First Eagle Investment Management LLC | Added | 3,241,361 | +16,022 | 2.94% | $1,409,862,551 | 42 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2025
- Filed
- May 15, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 278,400
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.